Nov 01, 2016 at 20:46 | Source: PTI
In contrast, shipment was up sequentially in the reported period at 9.8 per cent over the second quarter of 2016 as the bigger vendors prepared for the holiday quarter, IDC said in its preliminary data report.
Sep 28, 2016 at 19:00 | Source: PTI
After ordering the Income Tax department to keep its offices open till the midnight ofSeptember 30 to receive declarations under the one-time domestic black money window, the CBDT today asked it to extend its working hours till 8 PM for today and tomorrow in this regard.
Aug 10, 2016 at 19:20 | Source: PTI
The approval by the US health regulator for potassium chloride extended-release tablets USP are for multiple strengths of 8 mEq (600 mg) and 10 mEq (750 mg), Lupin said in a statement.
Jul 18, 2016 at 12:54 | Source: PTI
"As per the agreement, SPARC will licence Elepsia XRTM (Levetiracetam Extended Release tablets) to a wholly-owned subsidiary of Sun Pharma for the US market. SPARC will receive an up-front payment of USD 10 million from Sun Pharma," SPARC said in a BSE filing.
Jun 23, 2016 at 10:18 | Source: Moneycontrol.com
Share prices of Natco Pharma rose 8 percent intraday Thursday on the back of approval received from USFDA for Glycopyrrolate oral tablets.
Jun 06, 2016 at 12:36 | Source: PTI
According to IMS MAT March 2016 sales data, Vfend tablets, 50 mg and 200 mg, had sales of USD 92.8 million while Vfend Oral Suspension, 40 mg/mL, had US sales of USD 15.9 million.
May 25, 2016 at 17:16 | Source: PTI
The tablet features a 7-inch screen, 1.2 Ghz quadcore processor, 1.5GB RAM, 8GB memory (expandable up to 200GB), 5MP rear camera and 3,600 mAh battery.
May 24, 2016 at 21:22 | Source: PTI
However, shipment (of slate and detachables) remained flat compared to the October-December 2015 period, IDC said in a statement.
May 17, 2016 at 13:10 | Source: PTI
"The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Hydromorphone Hydrochloride tablets USP, 2 mg, 4 mg, and 8 mg," Aurobindo Pharma said in a BSE filing.
May 17, 2016 at 11:46 | Source: Moneycontrol.com
Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Hydromorphone Hydrochloride Tablets USP, 2 mg, 4 mg, and 8 mg.